Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24290900)

1.

Clinical characteristics and prediction of pulmonary hypertension in severe emphysema.

Minai OA, Fessler H, Stoller JK, Criner GJ, Scharf SM, Meli Y, Nutter B, DeCamp MM; NETT Research Group.

Respir Med. 2014 Mar;108(3):482-90. doi: 10.1016/j.rmed.2013.11.006. Epub 2013 Nov 19.

PMID:
24290900
2.

The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Adir Y, Ollech JE, Vainshelboim B, Shostak Y, Laor A, Kramer MR.

Lung. 2015 Apr;193(2):223-9. doi: 10.1007/s00408-015-9698-6. Epub 2015 Mar 7.

PMID:
25749664
3.

Is endoscopic lung volume reduction able to reverse pulmonary hypertension in patients with severe emphysema?

Bugalho A.

Respiration. 2015;89(1):12-4. doi: 10.1159/000368967. Epub 2014 Dec 6. No abstract available.

PMID:
25503809
4.

Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension.

Eberhardt R, Gerovasili V, Kontogianni K, Gompelmann D, Ehlken N, Herth FJ, Grünig E, Nagel C.

Respiration. 2015;89(1):41-8. doi: 10.1159/000368369. Epub 2014 Dec 4.

PMID:
25502235
5.

Can the development of severe hypertension be predicted?

Waeber B, Feihl F.

J Hypertens. 2014 Dec;32(12):2353-4. doi: 10.1097/HJH.0000000000000386. No abstract available.

PMID:
25376248
6.

Minimum clinically important difference in diffusing capacity of the lungs for carbon monoxide among patients with severe and very severe chronic obstructive pulmonary disease.

Horita N, Miyazawa N, Kojima R, Inoue M, Ishigatsubo Y, Kaneko T.

COPD. 2015 Feb;12(1):31-7. doi: 10.3109/15412555.2014.898051. Epub 2014 Jun 10.

PMID:
24915470
7.

Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.

Zhang J, Lin XF, Bai CX.

Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.

8.

Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.

Peinado VI, Gómez FP, Barberà JA, Roman A, Angels Montero M, Ramírez J, Roca J, Rodriguez-Roisin R.

J Heart Lung Transplant. 2013 Dec;32(12):1262-9. doi: 10.1016/j.healun.2013.09.007.

PMID:
24263025
9.

Computer quantification of airway collapse on forced expiration to predict the presence of emphysema.

Topalovic M, Exadaktylos V, Peeters A, Coolen J, Dewever W, Hemeryck M, Slagmolen P, Janssens K, Berckmans D, Decramer M, Janssens W.

Respir Res. 2013 Nov 19;14:131. doi: 10.1186/1465-9921-14-131.

10.

Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension.

Lacedonia D, Valerio G, Palladino GP, Carpagnano GE, Correale M, Di Biase M, Foschino Barbaro MP.

Rejuvenation Res. 2014 Feb;17(1):33-9. doi: 10.1089/rej.2013.1478.

PMID:
24228853
11.

CT signs of right ventricular dysfunction correlated with echocardiography-derived pulmonary arterial systolic pressure: incremental value of the pulmonary arterial diameter index.

Lim S, Lee H, Lee SJ, Kim JK, Suh J, Lee EH, Paik SH.

Int J Cardiovasc Imaging. 2013 Dec;29 Suppl 2:109-18. doi: 10.1007/s10554-013-0322-7. Epub 2013 Nov 6.

PMID:
24194372
12.

CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT.

Chest. 2014 Apr;145(4):824-32. doi: 10.1378/chest.13-1422.

13.

Tidal expiratory flow limitation at rest as a functional marker of pulmonary emphysema in moderate-to-severe COPD.

Chiari S, Bassini S, Braghini A, Corda L, Boni E, Tantucci C.

COPD. 2014 Feb;11(1):33-8. doi: 10.3109/15412555.2013.813929. Epub 2013 Oct 8.

PMID:
24102405
14.
15.

Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.

Bodlet A, Maury G, Jamart J, Dahlqvist C.

Respir Med. 2013 Nov;107(11):1781-8. doi: 10.1016/j.rmed.2013.08.039. Epub 2013 Sep 3.

PMID:
24051272
16.

[Importance of lung function for pulmonary hypertension in sarcoidosis].

Held M, Jonas-Klemm D, Jany BH.

Pneumologie. 2013 Sep;67(9):502-8. doi: 10.1055/s-0033-1344553. Epub 2013 Sep 4. German.

PMID:
24006196
17.

Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.

Schroeder JD, McKenzie AS, Zach JA, Wilson CG, Curran-Everett D, Stinson DS, Newell JD Jr, Lynch DA.

AJR Am J Roentgenol. 2013 Sep;201(3):W460-70. doi: 10.2214/AJR.12.10102.

18.

Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses.

Trip P, Nossent EJ, de Man FS, van den Berk IA, Boonstra A, Groepenhoff H, Leter EM, Westerhof N, Grünberg K, Bogaard HJ, Vonk-Noordegraaf A.

Eur Respir J. 2013 Dec;42(6):1575-85. doi: 10.1183/09031936.00184412. Epub 2013 Aug 15.

19.

Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension.

Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, Kane GC.

Circ Cardiovasc Imaging. 2013 Sep;6(5):711-21. doi: 10.1161/CIRCIMAGING.113.000640. Epub 2013 Jun 27.

20.

Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease.

Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S.

Respir Med. 2013 Aug;107(8):1271-9. doi: 10.1016/j.rmed.2013.03.021. Epub 2013 Jun 12.

PMID:
23768734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk